<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28905383</article-id>
<article-id pub-id-type="pmc">5685823</article-id>
<article-id pub-id-type="doi">10.1113/JP275087</article-id>
<article-id pub-id-type="publisher-id">TJP12628</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience ‐ neurobiology of disease</subject>
<subj-group subj-group-type="heading">
<subject>Editor's Choice</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Leukoencephalopathy‐causing <italic>CLCN2</italic> mutations are associated with impaired Cl<sup>−</sup> channel function and trafficking</article-title>
<alt-title alt-title-type="left-running-head">H. Gaitán‐Peñas and others</alt-title>
<alt-title alt-title-type="right-running-head"><italic>CLCN2</italic> mutations and GlialCAM</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp12628-cr-0001">
<name>
<surname>Gaitán‐Peñas</surname>
<given-names>Héctor</given-names>
</name>
<xref ref-type="aff" rid="tjp12628-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0002">
<name>
<surname>Apaja</surname>
<given-names>Pirjo M</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1622-2332</contrib-id>
<xref ref-type="aff" rid="tjp12628-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0003">
<name>
<surname>Arnedo</surname>
<given-names>Tanit</given-names>
</name>
<xref ref-type="aff" rid="tjp12628-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0004">
<name>
<surname>Castellanos</surname>
<given-names>Aida</given-names>
</name>
<xref ref-type="aff" rid="tjp12628-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0005">
<name>
<surname>Elorza‐Vidal</surname>
<given-names>Xabier</given-names>
</name>
<xref ref-type="aff" rid="tjp12628-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0006">
<name>
<surname>Soto</surname>
<given-names>David</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7995-3805</contrib-id>
<xref ref-type="aff" rid="tjp12628-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0007">
<name>
<surname>Gasull</surname>
<given-names>Xavier</given-names>
</name>
<xref ref-type="aff" rid="tjp12628-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp12628-cr-0008">
<name>
<surname>Lukacs</surname>
<given-names>Gergely L</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0900-0675</contrib-id>
<xref ref-type="aff" rid="tjp12628-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp12628-cr-0009">
<name>
<surname>Estévez</surname>
<given-names>Raúl</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1579-650X</contrib-id>
<address>
<email>restevez@ub.edu</email>
</address>
<xref ref-type="aff" rid="tjp12628-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp12628-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp12628-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Unitat de Fisiología, Departament de Ciències Fisiològiques, IDIBELL‐Institute of Neurosciences</named-content>
<institution>Universitat de Barcelona</institution>
<named-content content-type="street">L'Hospitalet de Llobregat</named-content>
<country country="ES">Spain</country>
</aff>
<aff id="tjp12628-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Centro de Investigación en Red de Enfermedades Raras (CIBERER)</named-content>
<institution>ISCIII</institution>
<country country="ES">Spain</country>
</aff>
<aff id="tjp12628-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Physiology</named-content>
<institution>McGill University</institution>
<named-content content-type="city">Montréal</named-content>
<named-content content-type="country-part">Quebec</named-content>
<named-content content-type="post-code">H3E 1Y6</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="tjp12628-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Research Group Focused on Protein Structure</named-content>
<institution>McGill University</institution>
<named-content content-type="city">Montréal</named-content>
<named-content content-type="country-part">Quebec</named-content>
<named-content content-type="post-code">H3E 1Y6</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="tjp12628-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">South Australian Health and Medical Research Institute</named-content>
<institution>Nutrition and Metabolism Theme and EMBL Australia</institution>
<named-content content-type="post-code">5000</named-content>
<named-content content-type="city">Adelaide</named-content>
<country country="AU">Australia</country>
</aff>
<aff id="tjp12628-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Neurophysiology Laboratory, Physiology Unit, Department of Biomedicine, Medical School, Institute of Neurosciences, IDIBAPS</named-content>
<institution>University of Barcelona</institution>
<named-content content-type="city">Barcelona</named-content>
<country country="ES">Spain</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> R. Estévez: Facultat de Medicina, Departament de Ciències Fisiològiques, IDIBELL‐Universitat de Barcelona, C/Feixa Llarga s/n 08907, L'Hospitalet de Llobregat, Barcelona, Spain. Email: <email>restevez@ub.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>595</volume>
<issue>22</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2017.595.issue-22</issue-id>
<fpage>6993</fpage>
<lpage>7008</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2017 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The Authors. The Journal of Physiology © 2017 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-595-6993.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="tjp12628-sec-0010">
<title>Key points</title>
<p>
<list id="tjp12628-list-0001" list-type="bullet"><list-item><p>Characterisation of most mutations found in <italic>CLCN2</italic> in patients with CC2L leukodystrophy show that they cause a reduction in function of the chloride channel ClC‐2.</p></list-item><list-item><p>GlialCAM, a regulatory subunit of ClC‐2 in glial cells and involved in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts (MLC), increases the activity of a ClC‐2 mutant by affecting ClC‐2 gating and by stabilising the mutant at the plasma membrane.</p></list-item><list-item><p>The stabilisation of ClC‐2 at the plasma membrane by GlialCAM depends on its localisation at cell–cell junctions.</p></list-item><list-item><p>The membrane protein MLC1, which is defective in MLC, also contributes to the stabilisation of ClC‐2 at the plasma membrane, providing further support for the view that GlialCAM, MLC1 and ClC‐2 form a protein complex in glial cells.</p></list-item></list>
</p>
</sec>
<sec id="tjp12628-sec-0020">
<title>Abstract</title>
<p>Mutations in <italic>CLCN2</italic> have been recently identified in patients suffering from a type of leukoencephalopathy involving intramyelinic oedema. Here, we characterised most of these mutations that reduce the function of the chloride channel ClC‐2 and impair its plasma membrane (PM) expression. Detailed biochemical and electrophysiological analyses of the Ala500Val mutation revealed that defective gating and increased cellular and PM turnover contributed to defective A500V‐ClC‐2 functional expression. Co‐expression of the adhesion molecule GlialCAM, which forms a tertiary complex with ClC‐2 and megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1), rescued the functional expression of the mutant by modifying its gating properties. GlialCAM also restored the PM levels of the channel by impeding its turnover at the PM. This rescue required ClC‐2 localisation to cell–cell junctions, since a GlialCAM mutant with compromised junctional localisation failed to rescue the impaired stability of mutant ClC‐2 at the PM. Wild‐type, but not mutant, ClC‐2 was also stabilised by MLC1 overexpression. We suggest that leukodystrophy‐causing <italic>CLCN2</italic> mutations reduce the functional expression of ClC‐2, which is partly counteracted by GlialCAM/MLC1‐mediated increase in the gating and stability of the channel.</p>
</sec>
</abstract>
<abstract abstract-type="toc" id="d35e413">
<title>Key points</title>
<p>
<list id="tjp12628-list-0002" list-type="bullet"><list-item><p>Characterisation of most mutations found in <italic>CLCN2</italic> in patients with CC2L leukodystrophy show that they cause a reduction in function of the chloride channel ClC‐2.</p></list-item><list-item><p>GlialCAM, a regulatory subunit of ClC‐2 in glial cells and involved in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts (MLC), increases the activity of a ClC‐2 mutant by affecting ClC‐2 gating and by stabilising the mutant at the plasma membrane.</p></list-item><list-item><p>The stabilisation of ClC‐2 at the plasma membrane by GlialCAM depends on its localisation at cell–cell junctions.</p></list-item><list-item><p>The membrane protein MLC1, which is defective in MLC, also contributes to the stabilisation of ClC‐2 at the plasma membrane, providing further support for the view that GlialCAM, MLC1 and ClC‐2 form a protein complex in glial cells.</p></list-item></list>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="tjp12628-kwd-0001">Leukodystrophy</kwd>
<kwd id="tjp12628-kwd-0002">chloride channel</kwd>
<kwd id="tjp12628-kwd-0003">ClC‐2</kwd>
<kwd id="tjp12628-kwd-0004">GlialCAM</kwd>
<kwd id="tjp12628-kwd-0005">MLC1</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>ICREA</funding-source>
<award-id>ICREA Academia Prize</award-id>
</award-group>
<award-group>
<funding-source>Canadian Institutes of Health Research</funding-source>
</award-group>
<award-group>
<funding-source>Generalitat de Catalunya</funding-source>
<award-id>2014 SGR 1178</award-id>
<award-id>2014 SGR 1165</award-id>
</award-group>
<award-group>
<funding-source>ELA Foundation</funding-source>
<award-id>2012‐014C2</award-id>
</award-group>
<award-group>
<funding-source>Instituto de Salud Carlos III</funding-source>
<award-id>ERARE2</award-id>
<award-id>FIS PI14/00141</award-id>
<award-id>RETIC RD12/0034/0003</award-id>
<award-id>RD16/0008/0014</award-id>
</award-group>
<award-group>
<funding-source>Ministerio de Ciencia e Innovación</funding-source>
<award-id>SAF2012‐31486</award-id>
<award-id>SAF2015‐70377‐R</award-id>
<award-id>BFU2014‐5762‐P</award-id>
</award-group>
<award-group>
<funding-source>Canada Research Chair</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="0"></table-count>
<page-count count="16"></page-count>
<word-count count="9307"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp12628</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 November 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.5 mode:remove_FC converted:14.11.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group>
<fn id="tjp12628-note-0001">
<p>H. Gaitán‐Peñas and P. M. Apaja contributed equally to this study.</p>
</fn>
<fn id="tjp12628-note-0010">
<p>This is an Editor's Choice article from the 15 November 2017 issue.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>